Immunosuppressive treatment for aplastic anemia: are we hitting the ceiling?

Haematologica. 2009 Mar;94(3):310-2. doi: 10.3324/haematol.2008.002329.

Abstract

The combination of antithymocyte globulin of horse origin and cyclosporine A is the standard treatment for aplastic anemia in patients not eligible for bone marrow transplantation. In this perspective article, Drs. Passweg and Tichelli discuss the current immunosuppressive therapy of aplastic anemia. See related article on page 348.

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anemia, Aplastic / drug therapy*
  • Antilymphocyte Serum / therapeutic use*
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Recurrence
  • Sirolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Cyclosporine
  • Sirolimus